Evaluation of a radionovela to promote HPV vaccine awareness and knowledge among Hispanic parents
- PMID: 21452030
- PMCID: PMC4065612
- DOI: 10.1007/s10900-011-9395-1
Evaluation of a radionovela to promote HPV vaccine awareness and knowledge among Hispanic parents
Abstract
Hispanic women have more than a 1.5-fold increased cervical cancer incidence and mortality compared to non-Hispanic white women in the United States. The Centers for Disease Control recommends the HPV vaccine for females at ages 11 and 12 years, though it is approved for females aged 9-26 to protect against the primary types of high-risk HPV (HPV-16 and HPV-18) that cause approximately 70% of cervical cancer cases. Few culturally-tailored Spanish HPV vaccine awareness programs have been developed. This study evaluates the efficacy of a Spanish radionovela as an educational tool. Rural Hispanic parents of daughters aged 9-17 (n = 88; 78 mothers and 10 fathers) were randomized to listen to the HPV vaccine radionovela or to another public service announcement. Participants completed a 30 min pretest posttest questionnaire. Parents who listened to the HPV radionovela (intervention group) scored higher on six knowledge and belief items. They were more likely to confirm that HPV is a common infection (70% vs. 48%, P = .002), to deny that women are able to detect HPV (53% vs. 31%, P = .003), to know vaccine age recommendations (87% vs. 68%, P = .003), and to confirm multiple doses (48% vs. 26%, P = .03) than control group parents. The HPV vaccine radionovela improved HPV and HPV vaccine knowledge and attitudes. Radionovela health education may be an efficacious strategy to increase HPV vaccine awareness among Hispanic parents.
References
-
- National Cancer Institute. SEER cancer statistics review, 1975– 2006. Bethesda, MD: http://seer.cancer.gov/csr/1975_2006/
-
- Adams EK, Breen N, Joski PJ. Impact of the national breast and cervical cancer early detection program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996–2000. Cancer. 2007;109(2 Suppl):348–358. - PubMed
-
- US Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. Silver Spring, MD: FDA News; 2006.
-
- US Food and Drug Administration. FDA approves new vaccine for prevention of cervical cancer. Silver Spring, MD: FDA News; 2009.
-
- National Cancer Institute. Human papillomaviruses and cancer: Questions and answers. Bethesda, MD: 2008. http://www.cancer.gov/cancertopics/factsheet/Risk/HPV. Reviewed 13 Dec 2010.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical